The Y2R is in the centre of NPY-associated anti-obesity research and, until recently, a central stimulation would have been assumed to reduce weight and be beneficial, while a blockage would have been assumed to increase body weight [25,26,40]. This evidence concerns the gene NPY and obesity due to melanocortin 4 receptor deficiency.